What Naturopathic BHRT Looks Like in Gilbert, AZ

What Is Bioidentical Hormone Replacement Therapy in Gilbert, AZ?

If you have been told your labs are "normal" but you still feel exhausted, foggy, or out of sorts, the pattern is usually the same. You went to your primary care provider, asked about hormones, and were told the numbers looked fine, or were offered an antidepressant, or were sent home with a sleep aid. The missing step is almost always a workup designed for the specific question, with reference ranges interpreted in the context of your symptoms rather than in isolation. Sometimes that means looking at sex hormones in detail. Sometimes it means looking at thyroid, adrenal, and sex hormones together. Which version is right depends on the patient.

Bioidentical hormone replacement therapy is a treatment approach that uses sex hormones (estradiol, progesterone, testosterone, DHEA) with a molecular structure matching the hormones the body already produces. When the workup indicates, bioidentical thyroid hormone (such as desiccated thyroid, T3, or T4) and bioidentical adrenal support may be prescribed alongside as part of integrated hormone care. The goal is to restore physiologic levels in patients whose own production has declined, and to do it with formulations and routes of delivery that minimize known risks.

At Regenerative Performance in Gilbert, Arizona, hormone care is led by Dr. Kaitlyn Myers, a naturopathic physician who works with women across the full hormonal arc (PMS and cycle issues, perimenopause, menopause, and post-menopause), with men whose energy, libido, mood, body composition, or sleep point to a testosterone problem, and with patients whose thyroid or adrenal patterns are contributing to symptoms that BHRT alone will not resolve. The workup happens before the prescription, not after.

This article covers what BHRT is, how a naturopathic approach differs from the high-volume hormone clinic model, who is and is not a candidate, what the first visit looks like, and what hormone options we use most often.

What Is Bioidentical Hormone Replacement Therapy?

Bioidentical hormone replacement therapy is hormone therapy that uses molecules identical in structure to the ones produced by the human body. The most commonly prescribed are 17-beta estradiol, estriol, micronized progesterone, testosterone, and DHEA. The defining feature is structure, not source. A bioidentical hormone can be FDA-approved (manufactured by a pharmaceutical company in standardized doses) or compounded (mixed by a licensed compounding pharmacy to a custom dose or formulation).

This is the most common point of confusion. Patients hear "bioidentical" and assume it means "compounded only," or assume it means "natural and therefore safer." Neither is quite right.

Bioidentical vs synthetic: structure, not source

Synthetic hormones used in older HRT regimens (for example, conjugated equine estrogens or medroxyprogesterone acetate) have a different molecular structure than the hormones the human body makes. The body responds to them through similar receptor pathways, but with a different downstream profile. Modern menopausal hormone therapy increasingly favors bioidentical formulations because of more predictable receptor binding and a better-studied safety profile in several populations (Flores VA, et al., Endocrine Reviews, 2021).

Compounded vs FDA-approved

The American College of Obstetricians and Gynecologists 2023 clinical consensus on compounded BHRT clarifies the practical decision tree. FDA-approved bioidentical estradiol (oral and transdermal), bioidentical progesterone (oral micronized), and combination products are appropriate first-line options for many patients because they have predictable potency, established dosing, and broad evidence (ACOG Clinical Consensus No. 6, 2023). Compounded formulations earn a place when an FDA-approved option is not available at the dose a patient needs, when a patient has an allergy to an inactive ingredient in a manufactured product, or when a less common combination is clinically warranted.

Because we practice personalized medicine, most patients in our practice receive compounded preparations. That lets us tailor the dose and the delivery system to exactly what the patient needs rather than defaulting to a manufactured strength that may not be the right fit. As one example, many men on commercial testosterone replacement react to the carrier oil used in the FDA-approved injection. We often prescribe compounded testosterone in a different carrier (such as MCT oil), which appears to produce fewer of those reactions. Compounding is a clinical tool, not a marketing tagline, and the decision to use it is made case by case.

How a Naturopathic Approach to BHRT Differs

A naturopathic approach to BHRT begins with a workup tailored to the patient, then chooses the formulation, dose, and route of delivery that fit both the workup and the patient's preferences. The contrast with a pellet-first clinic for women or a high-volume TRT clinic for men is not whether labs are run (most reputable clinics order labs), but in three specific places: dosing flexibility, what gets evaluated alongside the sex hormones, and what gets done in parallel with hormone replacement to make the hormones work.

Dosing flexibility (and why we do not use pellets)

For women, a pellet locks a patient into a dose for several months because the pellet is implanted and releases hormone over that time. If the dose turns out to be too high (over-suppression, side effects, mood changes) or too low (incomplete symptom relief), the patient is committed to that dose until the pellet wears off. We prefer formulations that allow real-time titration based on labs and clinical response, so the dose can move with the patient rather than the patient waiting on a pellet to clear.

For men, the comparable issue at high-volume TRT clinics is protocol-style dosing, which means pushing testosterone to the upper end of the reference range and routinely co-prescribing aromatase inhibitors like anastrozole regardless of estradiol levels, rather than dosing for the individual patient and titrating against response. Many men come to us specifically because the high-dose-plus-anastrozole template did not produce the result they were looking for, or did but with downstream issues.

What gets evaluated alongside sex hormones

Many TRT and pellet clinics use protocol-style dosing without individualizing for the upstream contributors that affect hormone status. Sex hormone levels can be influenced by sleep, stress, nutrition, gut function, blood sugar, body composition, life stage, and (when relevant) thyroid and adrenal function. A patient whose testosterone is low because of poor sleep and chronic stress may not need testosterone replacement at all once those upstream contributors are addressed. A patient whose perimenopausal symptoms are layered on top of underlying thyroid dysfunction needs both addressed in parallel.

The labs we run on a first BHRT visit reflect that picture-first approach, and the exact panel depends on the clinical question. For some patients that means a focused sex hormone panel. For others it means a sex hormone panel alongside the thyroid panel (TSH, free T3, free T4, reverse T3, antibodies), the adrenal panel (often a four-point salivary or urinary cortisol), and selected nutrient and metabolic markers. The goal is to evaluate enough to make a good decision, not to run every test on every patient.

This matters because hormone systems do not move in isolation. When one system is treated, the others tend to shift, which is why our follow-up cadence includes retesting other endocrine markers periodically rather than only the system we are dosing. A patient whose thyroid hormone is increased without parallel attention to adrenal output will sometimes feel worse before they feel better, because the adrenals cannot keep up with the metabolic demand a higher thyroid dose creates.

What gets done alongside hormones to make hormones work

The naturopathic side of BHRT is not the prescription. The prescription is the easy part. The harder and more impactful part is the parallel work that makes the hormones do their job: nutrition adapted to insulin sensitivity and body composition, targeted supplementation for cofactors the labs flag (vitamin D, magnesium, B12, iron, methylation support), sleep and stress protocols, structured exercise (resistance training is non-negotiable for both BHRT and TRT patients), and selective use of peptide therapy where the clinical picture supports it. A patient on the right dose of estradiol with poor sleep, no resistance training, and a diet that spikes blood sugar will not feel the way the dose is supposed to make them feel. A patient with the same prescription whose lifestyle and supplement layer is dialed in will.

This is the through-line of naturopathic medicine: address the upstream contributors first, then add the hormone, then track the result.

Shared decision-making and dose titration

The first prescription is rarely the right long-term prescription. Dosing is titrated based on response, on follow-up labs, and on whether the underlying contributors (sleep, stress, blood sugar, gut function, nutrient status) are being addressed in parallel. A patient who improves on a starting dose but does not get all the way there often needs the upstream pieces tightened up before the dose is escalated.

Route of delivery matters

This is the area where many BHRT clinics and patients are operating on outdated information. Not all routes of delivery carry the same risk profile.

A 2019 nested case-control study in BMJ analyzed more than 80,000 women in two large UK databases and found that oral estrogen significantly increased venous thromboembolism (VTE) risk while transdermal estrogen showed no measurable increase in VTE risk over baseline (Vinogradova Y, et al., BMJ, 2019). A 2021 review in the Journal of Clinical Endocrinology & Metabolism reinforced that route of delivery and formulation are central to cardiovascular risk decisions, not afterthoughts (Shufelt CL, Manson JE, JCEM, 2021).

In our practice, transdermal estradiol is strongly preferred over oral, and we do not use oral estrogen because of the documented thrombotic and stroke risks. Creams, patches, and injections each have their place; pellets carry the dose-flexibility limitation noted earlier, so we do not use them either.

Who Is a Candidate for BHRT?

BHRT is appropriate for several patient profiles. It is not appropriate for everyone, and that distinction is one of the most important parts of the workup.

Perimenopause (often the 40s)

Perimenopause typically starts in the early to mid 40s and lasts an average of 4 to 8 years before final menstruation. The pattern is irregular cycles, sleep that becomes broken without an obvious reason, mood changes that do not match life circumstances, hot flashes that come and go, and changes in libido, weight, or cognition. Hormones in perimenopause swing rather than fall in a straight line, which is part of why a single lab snapshot can miss what is actually happening.

Candidates for BHRT in perimenopause are women whose symptoms are interfering with sleep, work, relationships, or daily function, and whose workup confirms that hormonal change is a meaningful contributor.

Menopause and post-menopause

Once a woman has gone 12 consecutive months without a period, she is considered post-menopausal. The vasomotor symptoms (hot flashes, night sweats), genitourinary symptoms (vaginal dryness, urinary urgency), bone density loss, and changes in cardiovascular risk after menopause are all influenced by the loss of endogenous estrogen.

The American Heart Association's 2020 scientific statement on the menopause transition makes the case for what is sometimes called the timing hypothesis: starting hormone therapy in early menopause (typically within 10 years of menopause onset, or before age 60) carries a different cardiovascular risk profile than starting it 20 years later. The transition itself is a window where intervention has more leverage, and where decisions about hormone therapy should be made with that window in mind (El Khoudary SR, et al., Circulation, 2020).

Candidates for BHRT in menopause and post-menopause are women whose vasomotor symptoms, sleep disruption, genitourinary changes, mood changes, or bone density concerns are interfering with quality of life, particularly when the workup is happening within the timing-hypothesis window. The earlier the workup happens after menopause, the more options remain on the table.

Men with low or low-normal testosterone and matching symptoms

In men, testosterone replacement is appropriate when symptoms (low energy, low libido, mood change, loss of muscle mass, harder-to-shift body fat, sleep disruption) line up with the lab picture. The reference range bottom for total testosterone is set very low, so a number that the lab calls "normal" can still be low enough to drive real symptoms. A meaningful percentage of men we work with come in with testosterone in the lower portion of normal rather than below it, and we treat against the symptom-and-lab picture rather than waiting for the number to fall further.

A naturopathic workup includes a full panel (total and free testosterone, SHBG, estradiol, prolactin, complete blood count, lipids, and metabolic markers) before a decision is made. We also screen for the upstream contributors that suppress testosterone, because resolving those sometimes reduces (or eliminates) the need for replacement.

Candidates for testosterone replacement at our practice are men whose symptom-and-lab picture supports it AND who are committed to the parallel work (sleep, training, nutrition, stress) that keeps the dose conservative and the result durable.

Women and testosterone

Testosterone is not only a male hormone. The International Society for the Study of Women's Sexual Health 2021 clinical practice guideline supports systemic testosterone for postmenopausal women with hypoactive sexual desire disorder (HSDD) when other contributors have been addressed (Parish SJ, et al., J Sex Med, 2021). Doses for women are roughly one-tenth of male doses, with monitoring of total testosterone, free testosterone, and clinical response.

Candidates for systemic testosterone in women are typically post-menopausal patients with HSDD or low libido that has not responded to addressing other contributors first (sleep, stress, the estrogen and progesterone side of the workup, relationship and life-stage factors). Testosterone in women is rarely the only intervention; it is one piece of a fuller picture.

When BHRT is NOT appropriate

There are situations where hormone therapy is contraindicated or carries enough risk that the answer is no:

• Active or recent hormone-sensitive cancer (breast, endometrial, certain ovarian cancers)
• A recent venous thromboembolism, pulmonary embolism, or stroke
• Pregnancy or active breastfeeding
• Undiagnosed abnormal uterine bleeding
• Severe active liver disease

A history of one of these does not always close the door permanently, but it does change the conversation. A workup that surfaces these factors before a prescription is written is the workup we run.

What the First Visit Looks Like at Regenerative Performance

The first BHRT visit at our Gilbert clinic is built around getting the picture right.

The intake covers your symptoms, current and past medications, prior hormone therapy if any, surgical history, family history (with attention to cancer and clotting), sleep, stress, gut function, nutrient intake, and what you have already tried. We ask about how mornings feel, how energy moves through the day, how sleep breaks down, and what the cycle (if you still have one) is doing.

The lab panel ordered on a first visit is broader than what most patients have had before. It typically includes a full sex hormone panel, the full thyroid panel including reverse T3 and antibodies, a four-point cortisol if the pattern suggests adrenal involvement, fasting metabolic markers, and selected nutrients (vitamin D, B12, ferritin, magnesium where indicated).

A review visit walks through the labs in the context of what you reported at intake. The plan that comes out of that review is shared, not handed down. We discuss which formulation, which route, and which dose make sense for you given your risk profile and goals, and we agree on what change you should expect by the next follow-up.

Follow-up cadence depends on the regimen. Early in therapy, follow-up is typically at 6 to 12 weeks with repeat labs and dose adjustment. Once a stable dose is reached, lab monitoring moves to every 6 months for a year, then annually. Visit cadence with Dr. Myers typically remains every 3 months or so during that time, because she is also working on the other aspects of your health (sleep, stress, nutrition, gut function, exercise, supplements) from a naturopathic standpoint. The hormone is one input; the full plan is what produces the durable result.

If you are unsure whether BHRT is right for your situation, or you are traveling from outside the Phoenix area, you can also call 480-508-4226 and ask about a brief 15 minute discovery call.

Bioidentical Hormone Options We Prescribe

The formulations and routes used most often in naturopathic BHRT, with the clinical reasoning for each:

Estradiol and estriol (compounded E2/E3 cream is our default)

In our practice, Dr. Myers typically prescribes a compounded estradiol-and-estriol (E2/E3) cream rather than a single-hormone patch or an oral product. The compounded E2/E3 cream allows precise dosing flexibility that fixed patch strengths do not, and estriol contributes its own clinical benefits (cervical and vaginal tissue support, less proliferative signaling than estradiol alone) that the patient does not get from estradiol in isolation.

We do not use oral estrogen because of the documented thrombotic and stroke risks discussed above. Patients coming to us are typically seeking to avoid those risks specifically, and the transdermal compounded cream lets us deliver bioidentical estrogen support without the first-pass liver burden that drives the oral risk profile.

Micronized progesterone (oral, bedtime)

Women with an intact uterus on estrogen require progesterone to protect the endometrial lining. Oral micronized progesterone has two advantages worth knowing. First, it has a documented endometrial protective effect when dosed appropriately. Second, it has a clinically useful sleep benefit when taken at bedtime. A 2021 systematic review and meta-analysis of randomized controlled trials in JCEM found that oral micronized progesterone improved sleep quality in peri- and postmenopausal women (Nolan BJ, et al., JCEM, 2021). Synthetic progestins do not share this profile.

Testosterone (men and women, different doses)

For men, testosterone is delivered as injection or transdermal cream in our practice, with dose targeted to a physiologic range and monitored over time. (We do not use pellets for the dosing-flexibility reasons discussed earlier.) For women with HSDD, dosing is roughly one-tenth of a male dose with monitoring as described above.

DHEA and thyroid support when indicated

DHEA is added when adrenal labs and clinical picture support it, particularly in women with low DHEA-S and symptoms of fatigue or low libido that are not fully responding to estrogen and progesterone alone. Bioidentical thyroid hormone, when indicated, may be desiccated thyroid or selective T3 and T4 dosing. We titrate carefully against clinical markers (including morning resting pulse rate, where a 30 percent rise from baseline can signal that we are pushing into hyperthyroid range) rather than relying on TSH alone, which can lag clinical change by weeks.

Common Questions Patients Ask

Still have questions? The best way to get answers is a conversation. Call 480-508-4226.

Getting Started in Gilbert, Mesa, Chandler, and the East Valley

Naturopathic BHRT is a long-term relationship more than a single transaction. The first visit is the longest because it sets up everything that follows.

What to bring to your first visit: a list of current medications and supplements, copies of any prior hormone or thyroid labs you have, and a written sense of what is bothering you most and what change you are hoping for. The second item is more important than it sounds; clarity about goals lets us measure progress against something specific rather than vague wellness.

Dr. Myers leads BHRT, women's health, and men's hormone care at Regenerative Performance, and works alongside Dr. Drew Timmermans on patients whose hormone picture intersects with chronic musculoskeletal pain or recovery. The two sides of the practice complement each other where they overlap, and hormone care across both men and women is led by Dr. Myers.

About Dr. Kaitlyn Myers

Dr. Kaitlyn Myers, ND

Dr. Kaitlyn Myers is a naturopathic physician at Regenerative Performance in Gilbert, AZ. She leads the practice's hormone therapy, functional medicine, and internal medicine care. She works with women across the full hormonal arc and with men whose testosterone and metabolic picture warrant attention, treats thyroid and adrenal dysfunction, resolves chronic infections such as Lyme and mold toxicity, and uses comprehensive functional labs to uncover root causes. Dr. Myers is a graduate of Southwest College of Naturopathic Medicine in Tempe, Arizona, and practices an investigative, systems-based approach to complex chronic illness.